IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver-Reference-Cited by-同舟云学术

IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver

Published:2013-02-01 Issue:3 Volume:123 Page:1138-1156
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Liu Chunsheng,Billadeau Daniel D.,Abdelhakim Haitham,Leof Edward,Kaibuchi Kozo,Bernabeu Carmelo,Bloom George S.,Yang Liu,Boardman Lisa,Shah Vijay H.,Kang Ningling

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference60 articles.

1. TGFβ in Cancer

2. Fibroblasts in cancer

3. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression

4. Hepatic stellate cells: Partners in crime for liver metastases?

5. Mechanism of activation of the TGF-β receptor

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer;Experimental & Molecular Medicine;2024-09-02

2. In silico predicted compound targeting the IQGAP1-GRD domain selectively inhibits growth of human acute myeloid leukemia;Scientific Reports;2024-06-04

3. Targeting Src SH3 domain–mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis;Hepatology;2024-01-24

4. Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors;NAR Cancer;2024-01-09

5. A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM‐STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma;Advanced Science;2023-10-03